Product Code: RP-ID-10070825 |
Published Date: 21 Mar 2025 |
Region: Global |
Category: Healthcare & Pharmaceuticals |
Report ID: 10070825
Market Overview:
Meningitis Diagnosis and Treatment Market Segmentation by Type (Bacterial, Fungal, and Viral); by Tests (PCR Assay, Lateral Flow Assay, Latex Agglutination Tests, ELISA Tests, and Culture Tests); and by End Users (Hospitals, Diagnostics Centers, and Others)-Global Demand Analysis & Opportunity Outlook 2031
Global Meningitis Diagnosis and Treatment Market Highlights Over 2022 - 2031
The global meningitis diagnosis and treatment market catered the revenue figure of around USD 120 million in the year 2021 and is estimated to grow at a CAGR of ~3% over the forecast period, i.e., 2022 – 2031. The growth of the market can be attributed to the growing incidences of meningitis around the world and rapid technological upgradations for precise diagnosis of meningitis. Further, the higher prevalence of bacterial meningitis among people is expected to be a major reason adding to the market growth. According to the World Health Organization (WHO), nearly 1 in 10 people who are affected with bacterial meningitis die, and 1 in 5 show severe complications. Besides, increasing research & development (R&D) activities for identifying and diagnosis of various kinds of meningitis is anticipated to drive the market growth.
CLICK TO DOWNLOAD A SAMPLE REPORT
Meningitis is a medical illness in which the membranes that surround a person's brain and spinal cord become inflamed. Symptoms of meningitis include headaches, fever, and stiffness in the neck. Meningitis can be caused by a variety of factors, including ear infections, skull fractures, and, in rare cases, surgery. Additionally, germs enter the bloodstream and move to the brain and spinal cord, causing acute bacterial meningitis is also a major reason for meningitis. Blood cultures, imaging, and a spinal tap are tests conducted for meningitis diagnosis. Additionally, to detect swellings or inflammations, imaging procedures such as computerized tomography (CT) scans or magnetic resonance imaging (MRI) are performed.
The global meningitis diagnosis and treatment market is segmented on the basis of type, tests, and end users. The tests segment is further divided into PCR assay, lateral flow assay, latex agglutination tests, ELISA tests, and culture tests. Among these, the PCR assay segment is anticipated to hold the largest market size in value and is estimated to grow at a moderate CAGR over the forecast period. The growth of the segment can be associated with the application of PCR to accurately diagnose the disease within a limited time period. Moreover, constant development and launching of new PCR assays with more accurate diagnosis is anticipated to be a factor adding to the growth of the segment in the coming years.
Global Meningitis Diagnosis and Treatment Market Regional Synopsis
Regionally, the global meningitis diagnosis and treatment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America held the largest market share in the year 2021 as a result of sound development in the healthcare sector and higher adoption of advanced diagnostic devices. Alternatively, the market in Middle East & Africa region is estimated to witness generous growth by growing at a modest CAGR over the forecast period. The market growth can be majorly attributed to the prevalence of meningitis cases and the growing need for development in diagnostics. As per the Centers for Disease Control and Prevention (CDC), sub-Saharan Africa is known as the meningitis belt of the world accounting for the higher threat of disease. Every 5-12 years, 1000 cases per 100000 population is reported during the occurrence of a major epidemic of meningococcal meningitis in the region. Besides this, the healthcare sector in the Middle East & Africa region is expected to show a breakthrough in the upcoming years as a result of growing development in the region, which is also projected to boost the growth of the market in the region. Moreover, the focus of large companies in order to set up diagnostic centers and spread awareness about the treatment of the disease is likely to boost market growth in the forthcoming years.
Market Segmentation
Our in-depth analysis of the global meningitis diagnosis and treatment market includes the following segments:
By Type
-
Bacterial
-
Fungal
-
Viral
By Tests
-
PCR Assay
-
Lateral Flow Assay
-
Latex Agglutination Tests
-
ELISA Tests
-
Culture Tests
By End Users
-
Hospitals
-
Diagnostics Centers
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Meningitis Diagnosis and Treatment Market
Growth Drivers
-
Growing cases of meningitis
-
Technological development in devices for diagnosis
-
Growing R&D activities
Challenges
-
Lack of skilled workers
-
High cost of treatment
Key Companies Dominating the Global Meningitis Diagnosis and Treatment Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global meningitis diagnosis and treatment market that are included in our report are Pfizer Inc., GlaxoSmithKline plc, PerkinElmer Inc., SANOFI, Thermo Fisher Scientific Inc., Seegene Inc., Siemens Healthcare GmbH, Baxter, ELITechGroup, BIO-RAD LABORATORIES, INC., and others.
Latest Developments in the Global Meningitis Diagnosis and Treatment Market:
-
24 April 2020: SANOFI announced that the U.S Food and Drug Administration (FDA) has approved its new meningococcal (MenACWY) vaccination, MenQuadfi. This vaccine would prevent the spread of meningococcal disease among population of age 2 years and above.
-
07 February 2022: Thermo Fisher Scientific Inc. and the Dassault Systemes company, Medidata announced a multiyear partnership to improve clinical research site selection along with speedy patient enrollment in clinical trials.
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
- Pfizer Inc.
- GlaxoSmithKline plc
- PerkinElmer Inc.
- SANOFI
- Thermo Fisher Scientific Inc.
- Seegene Inc.
- Siemens Healthcare GmbH
- Baxter
- ELITechGroup
- BIO-RAD LABORATORIESINC.
Related Reports
Proof of Quality & Reliability
